e-learning
resources
Berlin 2008
Monday, 06.10.2008
Best of lung epithelial cells 2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of Interleukin-6 in pulmonary and systemic effects in a murine model of COPD
N. S. Pauwels, K. R. Bracke, T. Maes, G. F. Joos, G. G. Brusselle (Ghent, Belgium)
Source:
Annual Congress 2008 - Best of lung epithelial cells 2008
Session:
Best of lung epithelial cells 2008
Session type:
Oral Presentation
Number:
1760
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. S. Pauwels, K. R. Bracke, T. Maes, G. F. Joos, G. G. Brusselle (Ghent, Belgium). The role of Interleukin-6 in pulmonary and systemic effects in a murine model of COPD. Eur Respir J 2008; 32: Suppl. 52, 1760
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Rene Hummel - 29.10.2008 14:46
Mr Rene Hummel
Hi I am very interested in your Poster and hoped that you could email me a version of it. Regards Rene' Hummel. Neurosearch. Email: rhu@neurosearch.dk
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The role of leptin in pulmonary neutrophilia during murine acute lung injury
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Characterisation of endogenous IL-33 using a model of
Alternaria
-induced pulmonary inflammation
Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways
Year: 2012
Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007
Hyperhomocysteinemia promotes pulmonary emphysema in murine model of COPD
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019
IL-23 is essential to the development of elastase-induced pulmonary inflammation and emphysema
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Systemic inflammation in COPD – a role for infection?
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008
Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006
Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation
Source: Eur Respir J 2014; 43: 1306-1315
Year: 2014
Systemic inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
The role anti-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 122s
Year: 2003
Potential association between pulmonary hypertension in COPD and monocyte chemoattractant protein (MCP)-1
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Role of IL-11 in vascular function of pulmonary fibrosis patients
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations.
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016
IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Cigarette smoke induced pulmonary emphysema is attenuated in CCR6 deficient mice
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept